Westaim Biomedical
This article was originally published in The Tan Sheet
Executive Summary
Firm receives FDA clearance to market antimicrobial bandages for OTC use Feb. 21. Silver-based nanocrystalline coated bandage, a lower-dose version of Exeter, N.H.-based company's Acticoat burn and chronic wound dressings, is expected to reach market in about two years, firm says. New marketing clearance will allow Westaim to adapt technology to consumer products for local management of superficial wounds, cuts, scrapes, abrasions, lacerations and minor burns. Firm is seeking licensing partners among "the world's leading [OTC] bandage producers"